Oxycodone extended release capsules for the treatment of chronic pain

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain

Pain Ther.

Pergolizzi JV Jr, Taylor R Jr, LeQuang JA, Raffa RB, Bisney J

doi: 10.1007/s40122-018-0095-8.

RECOMMENDED

Back Pain

Analgesic efficacy, safety, and tolerability of a long-acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate-release oxycodone

doi: 10.2147/JPR.S168836.

Pain Relief

Tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a double-blind, randomized, placebo- and oxycodone controlled release-controlled study

Curr Med Res Opin.

Serrie A, Lange B, Steup A

doi: 10.1080/

RECOMMENDED

Chronic Pain

No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study

Am J Addict.

Latif ZE, Solli KK, Opheim A, Kunoe N, Benth JŠ, Krajci P, Sharma-Haase K, Tanum L

doi: 10.1111/ajad.12859.

Pain Relief

Efficacy and safety of tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled-release studies

Curr Med Res Opin.

Lange B, von Zabern D, Elling C, Dubois C

doi: 10.1080/

Chronic Pain

Children with Chronic Pain: Response Trajectories Following Intensive Pain Rehabilitation Treatment

J Pain.

Simons LE, Sieberg CB, Conroy C, Randall ET, Shulman J, Borsook D, Berde C, Sethna NF, Logan DE

doi: 10.1016/j.jpain.2017.10.005.

Chronic Pain

The Impact of Spatial Distribution of Pain on Long Term Trajectories for Chronic Pain Outcomes after Intensive Interdisciplinary Pain Treatment

Clin J Pain.

Williams SE, Homan KJ, Crowley SL, Pruitt DW, Collins AB, Deet ET, Samuel ND, John A, Banner K, Rose JB

doi: 10.1097/AJP.0000000000000793.

Chronic Pain

Early Changes in Pain Acceptance Predict Pain Outcomes in Interdisciplinary Treatment for Chronic Pain

J Clin Med.

Probst T, Jank R, Dreyer N, Seel S, Wagner R, Hanshans K, Reyersbach R, Mühlberger A, Lahmann C, Pieh C

doi: 10.3390/jcm8091373.

COMMENTED

Chronic PainPain Relief

Internal health locus of control as a predictor of pain reduction in multidisciplinary inpatient treatment for chronic pain: a retrospective study

J Pain Res.

Zuercher-Huerlimann E, Stewart JA, Egloff N, von Känel R, Studer M, Grosse Holtforth M

doi: 10.2147/JPR.S189442.

Related content

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain

Analgesic efficacy, safety, and tolerability of a long-acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate-release oxycodone

Tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a double-blind, randomized, placebo- and oxycodone controlled release-controlled study

No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study

Efficacy and safety of tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled-release studies

Children with Chronic Pain: Response Trajectories Following Intensive Pain Rehabilitation Treatment

The Impact of Spatial Distribution of Pain on Long Term Trajectories for Chronic Pain Outcomes after Intensive Interdisciplinary Pain Treatment

Early Changes in Pain Acceptance Predict Pain Outcomes in Interdisciplinary Treatment for Chronic Pain

Internal health locus of control as a predictor of pain reduction in multidisciplinary inpatient treatment for chronic pain: a retrospective study